The work shows the cellular and humoral responses to SARS-CoV-2 vaccination of 36 individuals with Down syndrome (DS) after one to three (V1) and six (V2) months.
Source: Ainhoa Gutiérrez-Cobos, Diego Real de Asúa, Arantzazu Alfranca, et al.
Health and Research - COVID-19Resources for Professionals